Wearable Artificial Organs Market Research on Demand, Growth, Trends and Forecast – 2032
The global Wearable Artificial Organs Market was valued at USD 8.43 billion in 2022 and is projected to reach USD 32.06 billion in 2032, exhibiting a compound annual growth rate (CAGR) of 16% during the forecast period. The increasing prevalence of chronic diseases such as heart failure, kidney failure, and liver failure, as well as unhealthy lifestyles, rising obesity rates, and the aging population, are the primary factors driving the growth of the market.
Additionally,
manufacturers are developing more effective, simple-to-use, and affordable wearable
artificial organs, such as the wearable artificial kidney and the wearable
artificial pancreas, to improve patients' quality of life.
Get a free sample PDF of the report,
visit @
https://www.reportsanddata.com/download-free-sample/6196
Governments
across the globe are also offering supportive policies and financial assistance
to encourage research and development in wearable artificial organs. For
instance, the U.S. government provided USD 200 million to the National
Institutes of Health to promote the development of wearable artificial organs.
Key players in the Wearable Artificial
Organs Market:
- Abiomed,
Inc.
- Asahi Kasei
Corporation
- Baxter
International Inc.
- Boston
Scientific Corporation
- Edward
Lifesciences Corporation
- Fresenius
Medical Care AG & Co. KGaA
- HeartWare
International, Inc.
- Medtronic
plc
- Nipro
Corporation
- SynCardia
Systems, LLC
Despite
the growing demand, the high costs of wearable artificial organs pose a
significant challenge to the market's growth, particularly for patients in
developing countries. Moreover, there is a lack of awareness about wearable
artificial organs and their associated benefits and risks.
To know more about the latest insights
of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6196
The
market is segmented into various product types, including kidneys, heart,
pancreas, lungs, and others. The kidney segment is projected to dominate the
market during the forecast period owing to the surging demand for renal
wearable artificial organs among patients awaiting a transplant.
The
heart segment is anticipated to record the highest Compound Annual Growth Rate
(CAGR) during the forecast period, attributed to technological advancements, a
shift towards sustainable construction methods, and increased adoption of smart
healthcare solutions. Additionally, the pancreas segment is predicted to hold a
significant revenue share due to the rising prevalence of diabetes and its
associated complications. Lastly, the lung segment is expected to exhibit moderate
revenue growth owing to the increasing incidence of respiratory illnesses.
Based
on application, the market is segmented into hospitals, clinics, and homecare.
The hospital segment is projected to hold the largest revenue share during the
forecast period due to the rising prevalence of chronic diseases that
necessitate the use of wearable artificial organs, such as kidney and lung
devices, in hospitals. Meanwhile, the clinic segment is expected to register
the highest CAGR due to the growing popularity of outpatient care, where
wearable artificial organs such as insulin pumps and continuous glucose
monitoring systems are commonly used.
In
conclusion, the global wearable artificial organs market is expected to witness
significant growth during the forecast period due to the rising prevalence of
chronic diseases, the development of effective and affordable wearable
artificial organs, supportive government policies, and technological
advancements. However, the high costs of wearable artificial organs and the
lack of awareness about their benefits and risks may hinder the market's
growth.
Request a customized copy of the
report @
https://www.reportsanddata.com/request-customization-form/6196
Thank you for reading our report. To inquire
about customization or any query about the report, please get in touch with us.
Our team will make sure the report is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company
that provides syndicated research reports, customized research reports, and
consulting services. Our solutions purely focus on your purpose to locate,
target, and analyze consumer behaviour shifts across demographics, across
industries, and help clients to make smarter business decisions. We offer
market intelligence studies ensuring relevant and fact-based research across
multiple industries, including Healthcare, Touch Points, Chemicals, Products,
and Energy. We consistently update our research offerings to ensure our clients
are aware of the latest trends existent in the market. Reports and Data has a
strong base of experienced analysts from varied areas of expertise. Our
industry experience and ability to develop a concrete solution to any research
problems provides our clients with the ability to secure an edge over their
respective competitors.
Contact:
John W, Head of Business
Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse
for more reports…
https://tripyar.com/go.php?https://www.reportsanddata.com/report-detail/endometrial-ablation-market
Comments
Post a Comment